ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $374,000 | +30.8% | 11,300 | +82.3% | 0.04% | +8.8% |
| Q1 2022 | $286,000 | -30.4% | 6,200 | +24.7% | 0.03% | -17.1% |
| Q2 2021 | $411,000 | +85.1% | 4,970 | +42.0% | 0.04% | +13.9% |
| Q4 2019 | $222,000 | -59.5% | 3,500 | -88.3% | 0.04% | -60.0% |
| Q1 2019 | $548,000 | +21.8% | 29,873 | -17.7% | 0.09% | +15.4% |
| Q4 2018 | $450,000 | +476.9% | 36,294 | +71.2% | 0.08% | +457.1% |
| Q4 2017 | $78,000 | – | 21,201 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |